Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Laurans Oy
OY
Dissolved
Y-tunnus 0174170-8
Yrjönkatu 26A-2613, 40100
Jyväskylä
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1968 · 58 years old
0 employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Laurans Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
124
0
2
1
0
Staff expenses
−8
−0
−0
−0
−0
EBITDA
49
−3
−3
−4
−3
Depreciation & amort.
—
−0
−0
−0
−0
EBIT
49
−3
−3
−4
−3
Net financials
−0
−0
0
3
4
Profit before tax
49
−3
−3
−1
1
Tax
10
−0
−0
−0
−0
Net profit
39
−3
−3
−1
1
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
335
297
267
236
216
Equity
316
278
258
234
216
Long-term debt
—
—
0
0
0
Short-term debt
19
19
9
2
0
Total debt
19
19
9
2
0
Financial ratios
5-year trend
EBITDA margin
-325500.0%
This company
15.8%
Market median
-2060227% vs market
2021
2025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2021
2025
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
2021
2025
Net profit margin
75800.0%
This company
8.1%
Market median
+935702% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
View
PDF
More on Laurans Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
